Virilism: Clinical Trials

3 trials for Virilism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow Virilism: new trials by email Literature Review of Virilism trials Research Report on Virilism

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment With Topical Eflornithin After Laser Treatment in Women With Facial Hirsutism
Eflornithine cream 11.5 w/w % - Hirsutism
Phase 4CompletedBispebjerg Hospital222012-01-012013-12-02
Evaluation of Eflornithine on Facial and Forearm Skin
Eflornithine hydrochloride - Hirsutism
Phase 4CompletedAllergan782004-11-302019-10-30
Effects of Metformin vs Oral Contraceptives on CV Risk Markers in PCOS
Metformin, Ethynyl-estradiol plus cyproterone acetate - Polycystic Ovary Syndrome
Phase 4CompletedHospital Universitario Ramon y Cajal502004-04-012007-01-31

Narrower conditions

Hirsutism (3)  ·  Hyperandrogenism (1)  ·  Polycystic Ovary Syndrome (1)

Broader conditions

Hair Diseases (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Signs and Symptoms (3)  ·  Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  46, XX Disorders of Sex Development (1)  ·  Adnexal Diseases (1)  ·  Adrenogenital Syndrome (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Cysts (1)  ·  Disorders of Sex Development (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)

Interventions

Eflornithine (2)  ·  Cyproterone Acetate (1)  ·  Ethinyl Estradiol (1)  ·  Metformin (1)

Sponsors

Allergan (1)  ·  Bispebjerg Hospital (1)  ·  Hospital Universitario Ramon y Cajal (1)

Countries

Denmark (1)  ·  Spain (1)

Top investigators

Elisabeth H Taudorf, MD (1)

Results publications

PMID 17536071, PMID 18375410, PMID 18997670, PMID 20730705

NIH funding

2004 (1)